These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 12878496)

  • 21. Increased miltefosine tolerance in clinical isolates of Leishmania donovani is associated with reduced drug accumulation, increased infectivity and resistance to oxidative stress.
    Deep DK; Singh R; Bhandari V; Verma A; Sharma V; Wajid S; Sundar S; Ramesh V; Dujardin JC; Salotra P
    PLoS Negl Trop Dis; 2017 Jun; 11(6):e0005641. PubMed ID: 28575060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of phospholipid species affected by miltefosine action in Leishmania donovani cultures using LC-ELSD, LC-ESI/MS, and multivariate data analysis.
    Imbert L; Ramos RG; Libong D; Abreu S; Loiseau PM; Chaminade P
    Anal Bioanal Chem; 2012 Jan; 402(3):1169-82. PubMed ID: 22065347
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic and transcriptomic alterations in Leishmania donovani lines experimentally resistant to antileishmanial drugs.
    Rastrojo A; García-Hernández R; Vargas P; Camacho E; Corvo L; Imamura H; Dujardin JC; Castanys S; Aguado B; Gamarro F; Requena JM
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):246-264. PubMed ID: 29689531
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro selection of miltefosine resistance in promastigotes of Leishmania donovani from Nepal: genomic and metabolomic characterization.
    Shaw CD; Lonchamp J; Downing T; Imamura H; Freeman TM; Cotton JA; Sanders M; Blackburn G; Dujardin JC; Rijal S; Khanal B; Illingworth CJ; Coombs GH; Carter KC
    Mol Microbiol; 2016 Mar; 99(6):1134-48. PubMed ID: 26713880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro.
    Ménez C; Buyse M; Besnard M; Farinotti R; Loiseau PM; Barratt G
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3793-800. PubMed ID: 16966395
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipase Precursor-Like Protein Promotes Miltefosine Tolerance in Leishmania donovani by Enhancing Parasite Infectivity and Eliciting Anti-inflammatory Responses in Host Macrophages.
    Deep DK; Singh R; Kulshrestha A; Wajid S; Salotra P
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30297367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Complex Interplay between Sphingolipid and Sterol Metabolism Revealed by Perturbations to the Leishmania Metabolome Caused by Miltefosine.
    Armitage EG; Alqaisi AQI; Godzien J; Peña I; Mbekeani AJ; Alonso-Herranz V; López-Gonzálvez Á; Martín J; Gabarro R; Denny PW; Barrett MP; Barbas C
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29463533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Miltefosine-unresponsive Leishmania donovani has a greater ability than miltefosine-responsive L. donovani to resist reactive oxygen species.
    Das M; Saudagar P; Sundar S; Dubey VK
    FEBS J; 2013 Oct; 280(19):4807-15. PubMed ID: 23890327
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leishmania resistance to miltefosine associated with genetic marker.
    Cojean S; Houzé S; Haouchine D; Huteau F; Lariven S; Hubert V; Michard F; Bories C; Pratlong F; Le Bras J; Loiseau PM; Matheron S
    Emerg Infect Dis; 2012 Apr; 18(4):704-6. PubMed ID: 22469394
    [No Abstract]   [Full Text] [Related]  

  • 30. Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice.
    Escobar P; Yardley V; Croft SL
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1872-5. PubMed ID: 11353640
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phenotypic adaptations of Leishmania donovani to recurrent miltefosine exposure and impact on sand fly infection.
    Hendrickx S; Van Bockstal L; Bulté D; Mondelaers A; Aslan H; Rivas L; Maes L; Caljon G
    Parasit Vectors; 2020 Feb; 13(1):96. PubMed ID: 32087758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short report: fluorescent Leishmania: application to anti-leishmanial drug testing.
    Singh N; Dube A
    Am J Trop Med Hyg; 2004 Oct; 71(4):400-2. PubMed ID: 15516633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In Vivo Selection of Paromomycin and Miltefosine Resistance in Leishmania donovani and L. infantum in a Syrian Hamster Model.
    Hendrickx S; Mondelaers A; Eberhardt E; Delputte P; Cos P; Maes L
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4714-8. PubMed ID: 26014955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies on the antileishmanial mechanism of action of the arylimidamide DB766: azole interactions and role of CYP5122A1.
    Pandharkar T; Zhu X; Mathur R; Jiang J; Schmittgen TD; Shaha C; Werbovetz KA
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4682-9. PubMed ID: 24890590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible mechanism of miltefosine-mediated death of Leishmania donovani.
    Verma NK; Dey CS
    Antimicrob Agents Chemother; 2004 Aug; 48(8):3010-5. PubMed ID: 15273114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel Agents against Miltefosine-Unresponsive Leishmania donovani.
    Das M; Saha G; Saikia AK; Dubey VK
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7826-9. PubMed ID: 26392497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanisms of experimental resistance of Leishmania to miltefosine: Implications for clinical use.
    Pérez-Victoria FJ; Sánchez-Cañete MP; Seifert K; Croft SL; Sundar S; Castanys S; Gamarro F
    Drug Resist Updat; 2006; 9(1-2):26-39. PubMed ID: 16814199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis.
    Vishwakarma P; Parmar N; Yadav PK; Chandrakar P; Kar S
    J Mol Med (Berl); 2016 Jun; 94(6):695-710. PubMed ID: 26830627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leishmania donovani chaperonin TCP1γ subunit protects miltefosine induced oxidative damage.
    Yadav S; Ali V; Singh Y; Kanojia S; Goyal N
    Int J Biol Macromol; 2020 Dec; 165(Pt B):2607-2620. PubMed ID: 33736277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanotized Curcumin and Miltefosine, a Potential Combination for Treatment of Experimental Visceral Leishmaniasis.
    Tiwari B; Pahuja R; Kumar P; Rath SK; Gupta KC; Goyal N
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.